Clinical Trials Directory

Trials / Completed

CompletedNCT02793505

Safety of Metformin in Pregnancy

Pregnancy Outcome Following Maternal Exposure to Metformin: a Collaborative ENTIS Study

Status
Completed
Phase
Study type
Observational
Enrollment
950 (actual)
Sponsor
Centre Hospitalier Universitaire Vaudois · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This study aims to better characterize the risk linked to metformin use during pregnancy, using a prospective multicentric cohort design enabling a large sample size, in evaluating the rate of birth defects after first trimester exposure, as well as several other pregnancy related outcomes.

Conditions

Interventions

TypeNameDescription
DRUGmetforminThis is not an intervention but an observed exposure.
DRUGany drug not known as a major teratogen or major fetotoxicantThis is not an intervention but an observed exposure.

Timeline

Start date
2014-01-01
Primary completion
2015-11-01
First posted
2016-06-08
Last updated
2016-06-08

Source: ClinicalTrials.gov record NCT02793505. Inclusion in this directory is not an endorsement.

Safety of Metformin in Pregnancy (NCT02793505) · Clinical Trials Directory